Esmer-Sánchez D, Alfaro-Sousa A, Álvarez TFF, Carmona-Sánchez R

Language: Spanish
References: 28
Page: 434-438
PDF size: 57.75 Kb.

ABSTRACT

Background. Peritonitis is a very rare condition that has been found on inmunocompromised patients and patients on peritoneal dialysis. Objective: To present one case of a patient with chronic abdominal pain that was found to have coccidioidomycosis. Case presentation: 50 year old female with 6 months of intermittent abdominal pain referred to right upper quadrant, nausea and vomiting, without fever or jaundice. On physical exam she had pain localized to right upper quadrant. An US was performed and reported a schleroatrophic and litiasic gallbladder. Exploratory laparoscopy was performed, the findings were diffuse lesions in the peritoneal cavity parietal and visceral, some of them were biopsied. A peritoneal coccidioidomycosis was reported and fluconazol treatment was started. Postoperatory evolution was unremarkable at 3 years. Conclusion: Coccidioideal peritonitis is a rare disease, most of the patients are asymptomatic and frequently diagnosed while working up other disease.

REFERENCES

1. Hagman HM, Madnick EG, D’Agostina AN, et al. Hyphal forms in the central nervous system of patients with coccidioidomycosis. Clin Infect Dis 2000; 30: 349-55.

2. Pappagianis D. Epidemiology of coccidioidomycosis. Curr Trop Med Mycol 1988; 2: 199-238.

3. Posada A. Un nuevo caso de micosis fungoidea con psorospermias. An Circ Med Argent 1892; 15: 585-97.

4. Chen KT. Coccidioidal peritonitis. Am J Clin Pathol 1983; 80: 514-6.

5. Phillips P, Ford B. Peritoneal coccidiodomycosis: case report and review. Clin Infect Dis 2000; 30: 971-6.

6. Dickson E. “Valley fever” of the San Joaquin Valley and fungus Coccidioides. Calif West Med 1937; 47: 151-5.

7. Castañón-Olivares LR, Aroch-Calderón A, Bazán-Mora E, Córdova-Martínez E. Coccidiodomicosis y su escaso conocimiento en nuestro país. Rev Fac Med UNAM 2004; 47: 145-48.

8. López-Márquez A, Hernández-Avendaño V, Durán Padilla MA, Cervera FN, Chávez-Macías L, Olvera-Rabiela J. Coccidiodomicosis diseminada con infección pulmonar, ganglionar y meníngea: caso con hallazgos post-mortem. Rev Med Hosp Gen Mex 2004; 67: 88-93.

9. Smith C, Beard R, Whiting E. Varieties of coccidioidal infection in relation to the epidemiology and control of the disease. Am J Public Health 1946; 36: 1394-402.

10. Calderón-Garcidueñas AL, Piña-Osuna K, Cerda-Flores RM. Estudio clínico-patológico de la coccidioidomicosis vinculada con el embarazo en cuatro mujeres mexicanas. Ginecol Obstet Mex 2004; 72: 451-4.

11. Frías-Salcedo JA, Pérez-López R, Padilla-González MA. Coccidioidomicosis miliar en inmunocomprometidos. Rev Sanid Milit Mex 2001; 55: 174-7.

12. Deteniski SC, Stevens DA. Coccidioidomycosis in compromised host. Medicine 1975; 54: 377-87.

13. Petersen E, Friedman B, Crowder E, et al. Coccidoidouria: clinical significance. Ann Intern Med 1976; 85: 34-8.

14. Jacobs P. Cutaneous coccidioidomycosis. In: Stevens DA, editors. Coccidioidomycosis: a text New York: Plenum Publishing; 1980, p. 213-24.

15. Deresinski SC. Coccidioidomycosis of the bone and joint. In: Stevens DA (ed.). Coccidioidomycosis: a text New York: Plenum Publishing; 1980, p. 195-211.

16. Abbott KC, Hypolite I, Tveit DJ, Hshieh P, Cruess D, Agodoa LY. Hospitalizations for fungal infections after initiation of chronic dialysis in the United States. Nephron 2001; 89: 426-32.

17. Jamidar PA, Campbell DR, Fishback JL, Klotz SA. Peritoneal coccidioidomycosis associated with human immunodeficiency virus infection. Gastroenterology 1992; 102: 1054-8.

18. Perez JA Jr, Arsura EL. Peritoneal coccidioidomycosis diagnosed incidentally at herniorrhaphy. West J Med 1993; 158: 406.

19. Dooley DP, Reddy RK, Smith CE. Coccidioidomycosis presenting as an omental mass. Clin Infect Dis 1994; 19: 802-3.

20. Zaichuk AI, Dotsenko SA, Matiushina NM. Omental coccidioidosis as a cause of gastrostasis in a patiet after vagotomy. Klin Khir 1991; 8: 71.

21. Buchmiller-Crair TL. Initial presentation of coccidioidomycosis during inguinal herniorrhaphy. Hernia 2003; 7: 92-4.

22. Stockman L, Clark KA, Hunt JM, et al. Evaluation of commercially available acridinium ester-labeled chemiluminescent DNA probes for culture identification of Blastomyces dermatitidis, Coccidioides immitis, Cryptococcus neoformans, and Histoplasma capsulatum. J Clin Microbiol 1993; 31: 845-50.

23. Galgiani JN, Ampel NM, Catanzaro A, et al. Practice guideline for the treatment of coccidioidomycosis. Infectious Diseases Society of America. Clin Infect Dis 2000; 30: 658-61.

24. Clemons KV, Stevens DA. Comparative efficacy of amphotericin B colloidal dispersion and amphotericin B deoxycholate suspension in treatment of murine coccidioidomycosis. Antimicrob Agents Chemother 1991; 35: 1829-33.

25. Clemons KV, Stevens DA. Efficacies of amphotericin B lipid complex (ABLC) and conventional amphotericin B against murine coccidioidomycosis. J Antimicrob Chemother 1992; 30: 353-63.

26. Catanzaro A, Galgiani JN, Levine BE, et al. Fluconazole in the treatment of chronic pulmonary and nonmeningeal disseminated coccidioidomycosis. NIAID Mycoses Study Group. Am J Med 1995; 98: 249-56.

27. Graybill JR, Stevens DA, Galgiani JN, Dismukes WE, Cloud GA. Itraconzole treatment of coccidioidomycosis. NAIAD Mycoses Study Group. Am J Med 1990; 89: 282-90.

28. Galgiani JN, Catanzaro A, Cloud GA, et al. Comparison of oral fluconazole and itraconazole for progressive, nonmeningeal coccidioidomycosis: a randomized, double-blind trial. Ann Intern Med 2000; 133: 676-86.